Altamira Therapeutics Provides Business Update and Reports First Half 2021 Financial Results
Commercial launch of Bentrio™ nasal spray in first EU markets, with plans to expand to additional European and international markets...
Day: September 8, 2021
9 Meters Biopharma, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
- Conference Dates: September 13th-15th -RALEIGH, NC / ACCESSWIRE / September 8, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a...
Halberd Corporation Appoints Anthony Mirabelli Vice-President, Mergers & Acquisitions
JACKSON CENTER, PA / ACCESSWIRE / September 8, 2021 / Halberd Corporation (OTC PINK:HALB) announced the appointment of Anthony Mirabelli...
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity RaiseREDWOOD CITY, CA / ACCESSWIRE / September 8,...
Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
TORONTO, ON / ACCESSWIRE / September 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental...
NLS Pharmaceutics to Participate in the 23rd Annual H.C. Wainwright Global Investment Conference
STANS, SWITZERLAND / ACCESSWIRE / September 8, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
CohBar Granted U.S. Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)
MENLO PARK, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
– Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy...
AIM ImmunoTech Submits Pre-IND Application to the FDA for Phase 2 Clinical Study of Ampligen as a Potential Infusion Therapy for Post-COVID-19 Cognitive Dysfunction
OCALA, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that is has submitted...
ResMed Announces Participation in the Bank of America Global Healthcare Conference
SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief...
Editas Medicine Names Emma Reeve to Board of Directors
Emma Reeve Editas Medicine today announced that it has appointed Emma Reeve to its Board of Directors. CAMBRIDGE, Mass., Sept. 08,...
Clover Health Integrates Clover Assistant with athenahealth’s Market-leading EHR
Clover-contracted providers have access to innovative clinical decision support to reduce unnecessary documentationNASHVILLE, Tenn., Sept. 08, 2021 (GLOBE NEWSWIRE) --...
Cerner Board Member Recognized as One of the Most Influential Black Corporate Directors by Savoy Magazine
KANSAS CITY, Mo., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, today announced...
Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
Boca Raton, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer
AUSTIN, Texas, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced that Benjamin Musher M.D., will chair...
AGENTIX Corporation and the National Health Research Institutions Announce Worldwide Exclusive License Agreements
New York, New York--(Newsfile Corp. - September 8, 2021) - AGENTIX Corp. (OTC Pink: AGTX), a pharmaceutical company focused on...
Izotropic Receives Notice of Allowance for New 3D X-Ray Beam Filter Patent From USPTO
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a...
The Edinburg Center Advances Evidence-Based Services Through Enhanced Netsmart Solutions
OVERLAND PARK, Kan.--(BUSINESS WIRE)--The Edinburg Center, a non-profit community-based services agency, advances its evidence-based services through enhanced components of the...
Verato Announces Expansions to Executive Leadership Team to Support Hyper Revenue and Customer Growth
Mark Erwich and Arti Pandit named as Chief Marketing and Chief Customer Experience Officers for rapidly expanding patient identity resolution...
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual...